16 unknown. 16 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 16 | Unknown 16 |
| Phase 2 | 4 | Unknown 4 |
Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects TQC2938 Injection, TQC2938 Placebo - Asthma | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 84 | 2023-06-13 | 2024-06-10 |
| Single Dose Clinical Trial of MG-ZG122 in Chinese Healthy Adult Subjects MG-ZG122 Humanized Monoclonal Antibody Injection, Placebo - Asthma | Phase 1 | Unknown | Shanghai Mabgeek Biotech.Co.Ltd | 34 | 2023-02-09 | 2024-02-23 |
| A Study of MG-K10 in Subjects With Asthma MG-K10, Placebo - Asthma | Phase 1 / Phase 2 | Unknown | Shanghai Mabgeek Biotech.Co.Ltd | 180 | 2022-07-05 | 2023-08-21 |
| A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals, FLOVENT DISKUS - Asthma, Bioequivalence | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 36 | 2022-05-11 | 2022-05-31 |
| A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma 610 30mg group, 610 100mg group, 610 300mg group - Asthma | Phase 1 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 24 | 2021-12-06 | 2022-10-18 |
| Airway Immune Response to Allergens (Use Lay Language Here) Segmental allergen challenge - Allergic Asthma, Allergy to Cats | Phase 1 | Unknown | JOSALYN CHO | 12 | 2021-10-28 | 2023-08-31 |
| A Trial of SHR-1703 in Asthma SHR-1703, placebo - Asthma | Phase 1 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 23 | 2021-10-12 | 2023-04-25 |
| Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers Test, Reference - Bioequivalence, Asthma | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 18 | 2021-10-01 | 2021-10-20 |
| A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals, FLOVENT DISKUS - Asthma, Bioequivalence | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 50 | 2021-08-13 | 2021-08-26 |
| A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers Test, Reference - Bioequivalence, Asthma | Phase 1 | Unknown | Respirent Pharmaceuticals Co Ltd. | 50 | 2021-01-18 | 2021-04-20 |
| Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma Budesonide, normal saline - Acute Asthma | Phase 1 | Unknown | University of Monastir | 60 | 2019-05-20 | 2019-07-11 |
| Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. Chanqin granules - Cough Variant Asthma | Phase 1 / Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 120 | 2017-11-01 | 2017-10-24 |
| Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects ZL-2102, Placebo matching ZL-2102 - Chronic Obstructive Pulmonary Disease, Asthma | Phase 1 | Unknown | Zai Lab Pty. Ltd. | 120 | 2015-03-01 | 2019-01-24 |
| The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions Allergen(Tree, Grass, Weeds) - Allergic Rhinitis, Asthma | Phase 1 / Phase 2 | Unknown | University Hospitals Cleveland Medical Center | 245 | 2013-04-01 | 2013-06-17 |
| Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol Aerolizer Followed by Inspiromatic, Inspiromatic followed by Aerolizer - Asthma | Phase 1 / Phase 2 | Unknown | Guy Steuer | 30 | 2012-10-01 | 2012-10-22 |
| Safety Study of Anti-Asthma Agent BMEC-1217B BMEC-1217B - Asthma | Phase 1 | Unknown | Medigreen Biotechnology Corp. | 32 | 2008-07-01 | 2008-09-04 |
Conjunctivitis, Allergic (2) · Rhinitis, Allergic (2) · Cough-Variant Asthma (1) · Dust Mite Allergy (1) · Hypersensitivity (1) · Idiopathic Pulmonary Fibrosis (1) · Inflammation (1) · Pulmonary Disease, Chronic Obstructive (1) · Pulmonary Eosinophilia (1)
Bronchial Diseases (16) · Hypersensitivity, Immediate (16) · Immune System Diseases (16) · Lung Diseases (16) · Lung Diseases, Obstructive (16) · Respiratory Hypersensitivity (16) · Respiratory Tract Diseases (16) · Hypersensitivity (15) · Conjunctival Diseases (2) · Conjunctivitis (2) · Eye Diseases (2) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Fluticasone (4) · Budesonide (2) · Salmeterol Xinafoate (2) · Formoterol Fumarate (1) · Population Groups (1) · Saline Solution (1) · nabiximols (1)
Respirent Pharmaceuticals Co Ltd. (4) · Shanghai Mabgeek Biotech.Co.Ltd (2) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. (1) · Guy Steuer (1) · JOSALYN CHO (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Medigreen Biotechnology Corp. (1) · Shanghai University of Traditional Chinese Medicine (1) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (1) · University Hospitals Cleveland Medical Center (1) · University of Monastir (1) · Zai Lab Pty. Ltd. (1)
China (6) · Greece (4) · United States (2) · Australia (1) · Israel (1) · Taiwan (1) · Tunisia (1)
Chrysoula Doxani, MD, MSc, PhD (3) · Devi K Jhaveri, D.O. (1) · Guy Steuer, M.D. (1) · Haig Tcheurekdjian, M.D. (1) · Horng-Chin Yan, M.D., Ph.D. (1) · Hui Zhao (1) · Ioannis Stefanidis, Professor (1) · Josalyn L Cho, MD (1) · Min Zhang, MD (1) · Nanshan Zhong, Medical PhD (1) · Qinghong Zhou, MD (1) · Soudani Marghli, Professor (1) · Wei Hu (1) · Xin Zhou, MD (1)
PMID 15764724, PMID 16164444, PMID 35870902, PMID 41144273, PMID 42212541